Cutting-edge genome research services via our state-of-the-art infrastructure and world class specialists
Genomics is critical to every field of life science research and we provide cutting-edge genome research services via our specialists with expertise in high throughput genomics, transcriptomics, epigenomics and bioinformatics.
Our genomics network includes a suite of state-of-the-art instrumentation covering short read and long read next generation sequencing, Sanger sequencing, microarray technology, and single cell capability.
The Bioplatforms genomics network is nationally distributed, ensuring researchers have access to both local engagement and national scale.
Our Genomics facilities
Australian Genome Research Facility (AGRF), a not-for-profit organisation, committed to quality and innovation.
Through their national network, AGRF provides access to innovative and leading technologies, enabling genomics in the biomedical, agricultural and environmental domains. From single gene analysis to whole genome sequencing, AGRF provides a full range of genomic capabilities and services with complementary bioinformatics across the entire biological spectrum, to academia, healthcare and commercial industries.
The Ramaciotti Centre for Genomics is a focus for the development and application of genomics and transcriptomics in Australia.
It is comprehensively equipped with the latest next-generation sequencing technology, single-cell genomics platforms and high throughput microarray systems and is accredited to ISO/IEC 17025.
The ACRF Biomolecular Resource Facility (BRF) is a core lab providing researchers with access to state of the art techniques for molecular, genetic and protein-based studies. Their team can implement and run new cutting-edge technologies in these fields and provide consultancy on projects using BRF services and equipment.
Our services are available to researchers at the John Curtin School of Medical Research and ANU, as well as the broader regional scientific community and clients from across Australia’s education, research and medical services community.
Our investment at the Garven-Weizmann Centre achieves two distinct and important objectives. The first, is to establish a national partnership between the major key single cell technology sites in Australia, thereby building the capacity to support and translate single cell technology oriented research. The second, is to evaluate the variation between sites and platforms and use this to develop an approach to standardise between labs. The initiative includes participants from Walter and Eliza Hall Institute, Murdoch Children’s Research Institute, Harry Perkins Medical Research Institute and the Garvan.
The resulting data from the program will be contributed to the Human Cell Atlas, and through doing so, will help establish the Australian research community in this large global initiative. The Human Cell Atlas is expected to be the largest scientific collaborative project ever conducted by humankind (in terms of funding and numbers of contributing scientists), and both for early access to data, and intellectual engagement, it is imperative that Australian scientists are closely involved.